{"slideshow_credits": null, "snippet": "A new Reuters Breakingviews calculator shows why investors seem to believe that a $100 billion-plus acquisition by Pfizer will probably happen.", "abstract": "A new Reuters Breakingviews calculator shows why investors seem to believe that a $100 billion-plus acquisition by Pfizer will probably happen.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Christopher", "role": "reported", "lastname": "HUGHES", "rank": 1, "organization": ""}], "original": "By CHRISTOPHER HUGHES"}, "web_url": "http://dealbook.nytimes.com/2014/05/15/the-right-price-for-astrazenecas-stock/", "lead_paragraph": null, "headline": {"main": "The Right Price for AstraZeneca's Stock", "kicker": "DealBook"}, "_id": "53750d9b38f0d82531278747", "word_count": "365", "multimedia": [{"height": 126, "url": "images/2014/05/17/business/dbpix-astrazeneca/dbpix-astrazeneca-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/05/17/business/dbpix-astrazeneca/dbpix-astrazeneca-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 900, "url": "images/2014/05/17/business/dbpix-astrazeneca/dbpix-astrazeneca-articleLarge.jpg", "legacy": {"xlarge": "images/2014/05/17/business/dbpix-astrazeneca/dbpix-astrazeneca-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "900"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/05/17/business/dbpix-astrazeneca/dbpix-astrazeneca-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/05/17/business/dbpix-astrazeneca/dbpix-astrazeneca-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-05-15T14:54:48Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": "2"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": "1"}, {"name": "subject", "value": "Stocks and Bonds", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}